Download PDF
Thorac Cardiovasc Surg 2025; 73(S 03): e46-e52
DOI: 10.1055/a-2731-5261
Pediatric and Congenital Cardiology

Update after 2023 ESC Guidelines for the Management of Infective Endocarditis (IE) – Regarding the National IE Guideline of the German Society of Pediatric Cardiology

Authors

  • Walter Knirsch 

    1   Division of Pediatric Cardiology, Pediatric Heart Center, Children's Research Center, University Children's Hospital Zurich, Switzerland
    2   University of Zurich, Zurich, Switzerland

  • Colin R. MacKenzie

    3   Institute of Medical Microbiology and Hospital Hygiene, University Hospital, Heinrich-Heine-University, Düsseldorf, Germany

  • Hans-Joachim Schäfers

    4   Department of Thoracic and Cardiovascular Surgery, Saarland University Medical Center, Homburg, Germany

  • Ruth Heying

    5   Department of Pediatric and Congenital Cardiology, University Hospitals Leuven, Belgium

  • Oktay Tutarel

    6   Department of Congenital Heart Disease – Pediatric Cardiology, Deutsches Herzzentrum der Charité (DHZC), Berlin, Germany

  • Carsten Rickers

    7   University Heart and Vascular Center, Adult Congenital Heart Disease, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Further Information
   Permissions and Reprints All articles of this category

Introduction

In 2023, new guidelines of the European Society of Cardiology (ESC) for the management of infective endocarditis (IE) were published.[1] These new 2023 ESC Guidelines also include changes in the management of IE in pediatric and adult patients with congenital heart disease (CHD). Therefore, we intend to comment on changes in comparison with the national German IE Guideline of the German Society of Pediatric Cardiology from 2022[1] by incorporating the new ESC Guideline a(https://register.awmf.org/de/leitlinien/detail/023-024).

The preceding ESC Guidelines were published in 2015,[2] and the following reasons led to the remake of 2023:

  • Increasing population at risk for IE

  • New data on different clinical scenarios in patients with IE

  • Increasing resistance of antibiotics for oral streptococci

  • The impact of new diagnostic modalities, including CT/nuclear imaging techniques, especially for patients with prosthetic valves and implantable cardiac devices.

Within the new 2023 ESC Guidelines, a large number of revised or new recommendations (>20) were summarized in an extensive publication (>100 pages, >850 references), including an update on antibiotic treatment. A paradigm change opens perspective for new optional outpatient and oral antibiotic treatment following 2 weeks of intravenous antibiotic treatment in stable (adult) patients with IE due to non-difficult-to-treat microorganisms.[1]

Within this comment, the authors of the national German Guideline summarize and discuss the most important new or revised recommendations with a focus on IE in pediatric or adult patients with CHD.

a Knirsch W, MacKenzie CR, Schäfers HJ, Heying B, Tutarel O, Rickers C. Infektiöse Endokarditis und Endokarditisprophylaxe. Leitlinie der DGPK (beschlossen 28.09.2022) http://www.kinderkardiologie.org/Leitlinien




Publication History

Received: 03 April 2025

Accepted: 03 August 2025

Article published online:
23 December 2025

© 2025. Thieme. All rights reserved.

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

 

  • References

  • 1 Delgado V, Ajmone Marsan N, de Waha S. et al; ESC Scientific Document Group. 2023 ESC Guidelines for the management of endocarditis. Eur Heart J 2023; 44 (39) 3948-4042
    CrossrefPubMedSearch in Google Scholar
  • 2 Habib G, Lancellotti P, Antunes MJ. et al; ESC Scientific Document Group. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J 2015; 36 (44) 3075-3128
    CrossrefPubMedSearch in Google Scholar
  • 3 Thornhill MH, Jones S, Prendergast B. et al. Quantifying infective endocarditis risk in patients with predisposing cardiac conditions. Eur Heart J 2018; 39 (07) 586-595
    CrossrefPubMedSearch in Google Scholar
  • 4 Kuijpers JM, Koolbergen DR, Groenink M. et al. Incidence, risk factors, and predictors of infective endocarditis in adult congenital heart disease: focus on the use of prosthetic material. Eur Heart J 2017; 38 (26) 2048-2056
    PubMedSearch in Google Scholar
  • 5 Rushani D, Kaufman JS, Ionescu-Ittu R. et al. Infective endocarditis in children with congenital heart disease: cumulative incidence and predictors. Circulation 2013; 128 (13) 1412-1419
    CrossrefPubMedSearch in Google Scholar
  • 6 Fowler VG, Durack DT, Selton-Suty C. et al. The 2023 Duke-International Society for Cardiovascular Infectious Diseases Criteria for Infective Endocarditis: Updating the Modified Duke Criteria. Clin Infect Dis 2023; 77 (04) 518-526
    CrossrefPubMedSearch in Google Scholar
  • 7 Jain V, Wang TKM, Bansal A. et al. Diagnostic performance of cardiac computed tomography versus transesophageal echocardiography in infective endocarditis: A contemporary comparative meta-analysis. J Cardiovasc Comput Tomogr 2021; 15 (04) 313-321
    PubMedSearch in Google Scholar
  • 8 Berdejo J, Shibayama K, Harada K. et al. Evaluation of vegetation size and its relationship with embolism in infective endocarditis: a real-time 3-dimensional transesophageal echocardiography study. Circ Cardiovasc Imaging 2014; 7 (01) 149-154
    PubMedSearch in Google Scholar
  • 9 Rouzet F, Chequer R, Benali K. et al. Respective performance of 18F-FDG PET and radiolabeled leukocyte scintigraphy for the diagnosis of prosthetic valve endocarditis. J Nucl Med 2014; 55 (12) 1980-1985
    CrossrefPubMedSearch in Google Scholar
  • 10 Cooper HA, Thompson EC, Laureno R. et al. Subclinical brain embolization in left-sided infective endocarditis: results from the evaluation by MRI of the brains of patients with left-sided intracardiac solid masses (EMBOLISM) pilot study. Circulation 2009; 120 (07) 585-591
    PubMedSearch in Google Scholar
  • 11 Erba PA, Slart RHJA. Radiolabeled-white blood cell imaging in cardiac device-related infective endocarditis: Worth all the effort?. JACC Cardiovasc Imaging 2020; 13 (08) 1752-1754
    PubMedSearch in Google Scholar
  • 12 Durack DT, Lukes AS, Bright DK. Duke Endocarditis Service. New criteria for diagnosis of infective endocarditis: Utilization of specific echocardiographic findings. Am J Med 1994; 96 (03) 200-209
    CrossrefPubMedSearch in Google Scholar
  • 13 Li JS, Sexton DJ, Mick N. et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000; 30 (04) 633-638
    CrossrefPubMedSearch in Google Scholar
  • 14 Papadimitriou-Olivgeris M, Monney P, Frank M. et al. Comparison of the 2015 and 2023 European Society of Cardiology versions of the Duke criteria among patients with suspected infective endocarditis. Clin Infect Dis 2024; 80: 777-783
    Search in Google Scholar
  • 15 Iversen K, Ihlemann N, Gill SU. et al. Partial oral versus intravenous antibiotic treatment of endocarditis. N Engl J Med 2019; 380 (05) 415-424
    CrossrefPubMedSearch in Google Scholar
  • 16 Iung B, Doco-Lecompte T, Chocron S. et al; AEPEI Study Group. Cardiac surgery during the acute phase of infective endocarditis: discrepancies between European Society of Cardiology guidelines and practices. Eur Heart J 2016; 37 (10) 840-848
    PubMedSearch in Google Scholar
  • 17 Østergaard L, Oestergaard LB, Lauridsen TK. et al. Long-term causes of death in patients with infective endocarditis who undergo medical therapy only or surgical treatment: a nationwide population-based study. Eur J Cardiothorac Surg 2018; 54 (05) 860-866
    PubMedSearch in Google Scholar
  • 18 Ramos-Martínez A, Calderón-Parra J, Miró JM. et al; Spanish Collaboration on Endocarditis—Grupo de Apoyo al Manejo de la Endocarditis Infecciosa en España (GAMES) (see Appendix). Effect of the type of surgical indication on mortality in patients with infective endocarditis who are rejected for surgical intervention. Int J Cardiol 2019; 282: 24-30
    PubMedSearch in Google Scholar
  • 19 Murphy DJ, Din M, Hage FG, Reyes E. Guidelines in review: Comparison of ESC and AHA guidance for the diagnosis and management of infective endocarditis in adults. J Nucl Cardiol 2019; 26 (01) 303-308
    PubMedSearch in Google Scholar